High level MLL amplification in AML and MDS.

被引：0
|
作者：
Dolan, M [1 ]
Hirsch, B [1 ]
Eckfeldt, J [1 ]
机构：
[1] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2000年 / 114卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
55
引用
收藏
页码：315 / 315
页数：1
相关论文
共 50 条
  • [31] New and comprehensive cytogenetic prognostication and categorization in MDS.
    Haase, Detlef
    Germing, Ulrich
    Schanz, Julie
    Pfeilstoecker, Michael
    Noesslinger, Thomas
    Hildebrandt, Barbara
    Kuendgen, Andrea
    Luebbert, Michael
    Giagounidis, Aristoteles
    Aul, Carlo
    Truemper, Lorenz
    Mueller, Thomas
    Valent, Peter
    Fonatsch, Christa
    Steidl, Christian
    BLOOD, 2006, 108 (11) : 77A - 77A
  • [32] MODELING AND TARGETING MLL-PTD/RUNX1 RELATED MDS/AML IN MOUSE
    Hayashi, Yoshihiro
    Zhang, Yue
    Yan, Xiaomei
    Sashida, Goro
    Xu, Zefeng
    Harada, Hironori
    Xiao, Zhijian
    Huang, Gang
    EXPERIMENTAL HEMATOLOGY, 2014, 42 (08) : S20 - S20
  • [33] Modeling and Targeting MLL-PTD/RUNX1 Related MDS/AML In Mouse
    Zhang, Yue
    Yan, Xiaomei
    Chen, Aili
    Sashida, Goro
    Xiao, Zhijian
    Huang, Gang
    BLOOD, 2013, 122 (21)
  • [34] Expression of wt1 transactivators PAX2 and PAX8 in a proportion of AML and MDS.
    Siehl, JM
    Keilholz, U
    Heufelder, K
    Thiel, E
    BLOOD, 2002, 100 (11) : 734A - 734A
  • [35] Quantitation of minimal residual disease using CD45 blast gating for the prediction of relapse in AML and MDS.
    Itoh, S
    Oyake, T
    Ono, Y
    Inoue, H
    Ishida, Y
    BLOOD, 2001, 98 (11) : 584A - 584A
  • [36] Relationship between return of normal marrow function and subsequent remission duration in newly-diagnosed AML/MDS.
    Dwivedy, S
    Estrov, Z
    Elihu, E
    BLOOD, 1999, 94 (10) : 293A - 293A
  • [37] AML / MDS
    Bone Marrow Transplantation, 2002, 29 (Suppl 2) : S54 - S57
  • [38] High levels of homocysteinemia (HH) specifically correlate with autoimmunity and cardiovascular disease in MDS.
    Cortelezzi, A
    Fracchiolla, NS
    Motta, M
    Bamonti-Catena, F
    Novembrino, C
    Cighetti, G
    Sarina, B
    Calori, R
    Cattaneo, C
    Maiolo, AT
    Lambertenghi-Deliliers, G
    BLOOD, 1999, 94 (10) : 108A - 109A
  • [39] Is amplification of c-MYC, MLL and RUNX1 genes in AML and MDS patients with trisomy 8, 11 and 21 a factor for a clonal evolution in the karyotype?
    Angelova, S.
    Spassov, B.
    Nikolova, V.
    Christov, I.
    Tzvetkov, N.
    Simeonova, M.
    CYTOLOGY AND GENETICS, 2015, 49 (03) : 165 - 172
  • [40] Is amplification of c-MYC, MLL and RUNX1 genes in AML and MDS patients with trisomy 8, 11 and 21 a factor for a clonal evolution in the karyotype?
    S. Angelova
    B. Spassov
    V. Nikolova
    I. Christov
    N. Tzvetkov
    M. Simeonova
    Cytology and Genetics, 2015, 49 : 165 - 172
12345